Purchase Order 75N95021P00539

<p>The National Institute on Drug Abuse awarded a purchase order to Qiagen, LLC on September 16, 2021, with a firm fixed price ceiling value of $24,943.02 to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Place of performance is Baltimore, Maryland. The order's ultimate completion date was October 16, 2021.</p>

The National Institute on Drug Abuse issued a purchase order to The Johns Hopkins University valued at $49,765.87 on September 21, 2021, to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these funds. Work is performed in Baltimore, Maryland. The order carries firm fixed-price pricing with an ultimate completion date of September 21, 2022....

The National Institute on Drug Abuse issued a purchase order to David Kopf Instruments valued at $12,835.09 on September 6, 2021, to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. No set-aside was used. Place of performance is Baltimore, Maryland. The order carries a firm fixed price and an ultimate completion date of October 4, 2021.

The National Institute on Drug Abuse issued a purchase order to Children's Hospital Medical Center valued at $28,175.00 on July 31, 2018, to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these fiscal year funds. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion...

The National Institute on Drug Abuse issued a purchase order to Government Scientific Source Inc., a small business, for $9,679.68 on February 18, 2021. The order was firm fixed price with no set-aside designation. Place of performance was Baltimore, Maryland. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability...

The National Institute on Drug Abuse awarded a purchase order to Quanterix Corporation for $46,936.00 on July 1, 2021, to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with final completion by September 30, 2023. Work is performed in Billerica, Massachusetts. The purchase order carries no set-aside designation and is priced on a firm fixed-price basis. The period of performance covers July 1, 2021 through June 30,...

The National Institute on Drug Abuse awarded a purchase order to Eckert &amp; Ziegler Radiopharma, Inc. for $76,350.00 on September 14, 2021. This firm fixed-price purchase order is for the administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these funds. The ultimate completion date is November 30, 2021. Work is performed in Wilmington,...

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation valued at $43,171.69 on December 14, 2018, for service contract renewal, with an ultimate completion date of December 13, 2021. This is a firm fixed price, no-set-aside simplified acquisition. Place of performance is Carlsbad, California. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September...

The National Institute on Drug Abuse awarded a purchase order to Eurofins Discoverx LLC for $24,293.10 in testing compounds on September 17, 2021, with ultimate completion on September 17, 2022. The order was issued as a firm fixed price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of fund availability. Work is performed in Fremont, California. No set-aside was used.

The National Institute on Drug Abuse issued a purchase order to Psomagen Inc. on September 14, 2021, valued at $78,405.00 for epigenome sequencing services using NovaSeq technology. The order was placed to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability closure. Work was performed in Rockville, Maryland. The order carried a firm fixed price and an ultimate completion date of September...